Karyopharm Therapeutics Inc. (KPTI)
NASDAQ: KPTI · Real-Time Price · USD
0.4632
+0.0388 (9.14%)
Oct 22, 2026, 11:06 AM EDT - Market open
KPTI's stock price has decreased by -92.25% in the past year and price targets may not have had time to catch up.
Karyopharm Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $3.68 | Buy | Maintains | $3.68 | +694.47% | Sep 1, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $8 | Buy | Maintains | $8 | +1,627.12% | Aug 13, 2026 |
| Jefferies | Jefferies | Buy Maintains $14 → $11 | Buy | Maintains | $14 → $11 | +2,274.78% | Jul 31, 2026 |
| Robert W. Baird | Robert W. Baird | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | Jul 31, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $16 → $7 | Buy | Maintains | $16 → $7 | +1,411.23% | Jul 31, 2026 |
| H.C. Wainwright | H.C. Wainwright | Hold Downgrades $13 → $3 | Hold | Downgrades | $13 → $3 | +547.67% | Jul 31, 2026 |
Unknown Analyst Leerink Partners No rating | Leerink Partners | Hold Reiterates $5 → $7 | Hold | Reiterates | $5 → $7 | +1,411.23% | May 15, 2026 |